Myofascial Release and 20-m Speed in Wheelchair Rugby Athletes With Spinal Cord Injury

NCT07711015 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2026-07-17

No results posted yet for this study

Summary

This study aims to investigate the effect of myofascial release on sprint performance in wheelchair rugby athletes with spinal cord injury.

Participants will complete a 20-meter sprint test on two different days in a randomized crossover design: one day without myofascial release and one day immediately after the intervention.

The myofascial release will be applied to the upper limb muscles involved in wheelchair propulsion using a handheld device for 90 seconds per muscle group.

Sprint performance will be measured by the time required to complete the 20-meter distance.

The study will compare performance between conditions to determine whether myofascial release improves speed.

Conditions

  • Spinal Cord Injuries (SCI)

Interventions

OTHER

Myofascial Release

Manual myofascial release will be applied to the upper limb muscles involved in wheelchair propulsion, including the biceps brachii, brachialis, and triceps muscles. The intervention will be performed by a trained physiotherapist using a handheld device, with 90 seconds of application per muscle group. The treatment will be administered immediately prior to the 20-meter wheelchair sprint test

Sponsors & Collaborators

  • Centro Universitário Augusto Motta

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-17
Primary Completion
2026-09-27
Completion
2026-09-27

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07711015 on ClinicalTrials.gov